We are thrilled to announce that our team has been awarded an NIH-RO1 grant of over $3 million to develop a novel wearable device for objective quantification of visceral pain.

In collaboration with Dr. Bin Feng from UConn BME, Dr. Xiaomei Cong from Yale, and Dr. Wendy Henderson from UPenn, our team will be working on the project titled “Objective Integrated Multimodal Electrophysiological Index for Qualification of Visceral Pain.”
This innovative project aims to create a wearable device that objectively measures and quantifies visceral pain in patients with irritable bowel syndrome (IBS). By integrating data from electrodermal activity (EDA), electrocardiogram (ECG), and electromyogram (EMG), the device will employ artificial intelligence to generate a multimodal biomarker known as the OIME index. This index will enhance our ability to detect pain events, assess pain levels, stratify IBS patients, and evaluate the effectiveness of pain management interventions. The ultimate goal is to develop a more accurate and objective tool for diagnosing and treating IBS-related pain, which has the potential to significantly improve patient outcomes and pave the way for new non-drug therapies.

---